Evaluating the efficacy of moving cupping for chronic low back pain using shear wave elastography: A parallel-arm, randomized controlled trial.

Researchers are developing a new way to objectively measure whether moving cupping therapy helps people with chronic low back pain. Moving cupping is a traditional therapy where cups are applied to the skin and moved across painful areas to help relax muscles and reduce pain. While many people report feeling better after cupping, doctors have struggled to measure exactly how well it works using objective medical tests.

This study will involve 68 patients with chronic low back pain who will be randomly divided into two groups. One group will receive real moving cupping therapy twice weekly for two weeks, while the other receives a placebo treatment. What makes this study unique is that researchers will use shear wave elastography—a specialized ultrasound technology—to actually measure muscle stiffness before treatment, after two weeks of treatment, and one week later. They'll also track patients' pain levels and quality of life.

Shear wave elastography works by sending sound waves through muscle tissue to measure how stiff or relaxed the muscles are. This gives doctors concrete, measurable data rather than relying only on patients' descriptions of their pain. The researchers expect that moving cupping will help relax tight back muscles and reduce pain in people with chronic low back pain.

This research is important because it could finally provide objective evidence for whether cupping therapy truly works for back pain. If successful, this measurement technique could be used to evaluate other traditional therapies as well. If you're considering cupping therapy for back pain, seek treatment from a qualified, licensed acupuncturist or traditional Chinese medicine practitioner.

This randomized controlled trial protocol aims to objectively evaluate moving cupping therapy for chronic low back pain (CLBP) using shear wave elastography (SWE). The study will recruit 68 CLBP patients randomized to treatment or placebo control groups. The intervention consists of moving cupping therapy administered twice weekly for two weeks. SWE—an ultrasound-based technology that quantifies tissue stiffness—will serve as the primary objective outcome measure, assessed at baseline, post-treatment (2 weeks), and one-week follow-up. Secondary outcomes include pain intensity and quality of life measures.

This protocol addresses a significant methodological gap in complementary therapy research by incorporating objective biomechanical assessment alongside subjective patient-reported outcomes. SWE provides quantifiable data on paraspinal muscle stiffness, potentially validating the mechanism by which moving cupping induces muscle relaxation. The study design may establish a reproducible framework for objectively evaluating manual therapies in clinical practice. If successful, this approach could provide evidence-based validation for moving cupping as a noninvasive, cost-effective intervention for CLBP management.